The COVID-19 vaccine developed by Pfizer and BioNTech SE was able to neutralize a new variant of the coronavirus spreading rapidly in Brazil, according to a laboratory study published in the New England Journal of Medicine on Monday and cited by Reuters.
Blood taken from people who had been given the vaccine neutralized an engineered version of the virus that contained the same mutations carried on the spike portion of the highly contagious P.1 variant first identified in Brazil, found the study which was conducted by scientists from the companies and the University of Texas Medical Branch found.
Read more